T-Therapeutics
PrivateLast Round
Series A
Nov 13, 2025
Total Funding Raised
$91M
Momentum Score
25 /100
Company Overview
T-Therapeutics is a biopharmaceutical company focused on developing engineered soluble biologics for cancer and immune-related conditions using a proprietary T cell receptor discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
T-Therapeutics Comps
Public and private peers based on sector, stage, and business model.
T-Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 13, 2025 | ||||
| Series A | Nov 15, 2023 |
T-Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Digitalis Ventures | Series A |
| BGF | Series A |
| F-Prime Capital | Series A |
| University of Cambridge Seed Fund | Series A |
| Cambridge Innovation Capital | Series A |
| F-Prime Capital | Series A |
| Sanofi Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 13, 2025
$32M raised in Series A Extension round.
- Mar 9, 2025
Theodora Harold named new Chief Executive Officer.
T-Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about T-Therapeutics's valuation, stock price, and market status.
